Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (131-140 of 721) with videos related to

Pageof 73
Sort By:
European Urology Focus|February 26, 2023
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate CancerBarış Esen, Ken Herrmann, Sevil Bavbek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2019
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patientsSofia Vaz, Boris Hadaschik, Michael Gabriel, et al.
Practical Laboratory Medicine|August 13, 2021
Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assaysMartina Broecker-Preuss, Irina Mehnert, Elena Gilman, et al.
Journal of Neuroendocrinology|November 9, 2024
Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkersGrace Kong, Geertje Noe, Cherie Chiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
What Is Theranostics?Wolfgang A Weber, Henryk Barthel, Frank Bengel, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 23, 2023
Bone Metastases in Patients with Pancreatic NETs: Prevalence and PrognosisAnnie Mathew, Wolfgang P Fendler, Jens Theysohn, et al.
Annals of Nuclear Medicine|August 21, 2014
68Gallium- and 90Yttrium-/ 177Lutetium: "theranostic twins" for diagnosis and treatment of NETsRudolf A Werner, Christina Bluemel, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and BeyondAman Chauhan, Andrew E Hendifar, Ghassan El-Haddad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Imaging the Inflammatory Response in Checkpoint Inhibition MyocarditisChristoph Rischpler, Tienush Rassaf, Lale Umutlu, et al.
Seminars in Radiation Oncology|June 14, 2025
Radiopharmaceuticals in Prostate Cancer: General Considerations and Utility in Combination With EBRTCaner Civan, Nika Guberina, Ulrich Krafft, et al.
Pageof 73

Showing results (131-140 of 721) with videos related to

Sort By:
Pageof 73
European Urology Focus|February 26, 2023
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate CancerBarış Esen, Ken Herrmann, Sevil Bavbek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2019
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patientsSofia Vaz, Boris Hadaschik, Michael Gabriel, et al.
Practical Laboratory Medicine|August 13, 2021
Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assaysMartina Broecker-Preuss, Irina Mehnert, Elena Gilman, et al.
Journal of Neuroendocrinology|November 9, 2024
Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkersGrace Kong, Geertje Noe, Cherie Chiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
What Is Theranostics?Wolfgang A Weber, Henryk Barthel, Frank Bengel, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 23, 2023
Bone Metastases in Patients with Pancreatic NETs: Prevalence and PrognosisAnnie Mathew, Wolfgang P Fendler, Jens Theysohn, et al.
Annals of Nuclear Medicine|August 21, 2014
68Gallium- and 90Yttrium-/ 177Lutetium: "theranostic twins" for diagnosis and treatment of NETsRudolf A Werner, Christina Bluemel, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and BeyondAman Chauhan, Andrew E Hendifar, Ghassan El-Haddad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Imaging the Inflammatory Response in Checkpoint Inhibition MyocarditisChristoph Rischpler, Tienush Rassaf, Lale Umutlu, et al.
Seminars in Radiation Oncology|June 14, 2025
Radiopharmaceuticals in Prostate Cancer: General Considerations and Utility in Combination With EBRTCaner Civan, Nika Guberina, Ulrich Krafft, et al.
Pageof 73